mobile
news-insights-top

News & Insight

At Palisade Capital Management, we think differently than other asset managers. We believe in sharing ideas and research across teams—and now with you. Here you can gain access to our vast intellectual capital and decidedly different perspective, while seeing what we’ve been up to lately.



Thursday, July 25, 2013
The Incredible Shrinking Stock Market and the Case for Small Cap Investing
Posted in White Papers
On July 25, 2013 Palisade Capital Management published Chief Investment Officer – Institutional Dennison “Dan” T. Veru’s white paper entitled “The Incredible Shrinking Stock Market and the Case for Small Cap Investing”, which outlines Dan’s thoughts on small cap investing in the current market environment. Contact us today for a free copy of this report.
Thursday, June 27, 2013
Palisade Capital Management CIO - Institutional Dennison T. Veru Appears on Fox Business News “Countdown to the Closing Bell”.
Posted in Media Appearances
On June 27, 2013, Palisade Capital’s Chief Investment Officer - Institutional Dennison T. Veru appeared on Fox Business News “Countdown to the Closing Bell”. View his appearance: “Are Small-Cap Stocks the Place to Be?"
Wednesday, April 17, 2013
Donna Szczupak joins Palisade Capital as a Staff Accountant
Posted in Announcements
Donna Szczupak joined Palisade Capital in April 2013 as a Staff Accountant. Ms. Szczupak’s responsibilities include bookkeeping, payroll, and assisting the Chief Financial Officer and Chief Operating Officer in preparing analyses and reports. Ms. Szczupak reports to Palisade Capital’s Chief Financial Officer.
Read More
Tuesday, February 26, 2013
PCEPII Portfolio Company Brickell Biotech announces $7M Series B financing; AMOREPACIFIC Group, the largest cosmetic and aesthetics company in Korea, leads financing and becomes strategic partner
Posted in Private Equity News
Brickell Biotech, Inc. ("Brickell"), a development-stage pharmaceutical company focused on the development of innovative drug therapies for the treatment of skin diseases, today announced a $7 million Series B financing round. Brickell's current pipeline includes new chemical entities in dermatology for indications including acne, atopic dermatitis, and hyperhidrosis.
Wednesday, November 14, 2012
Palisade Capital Management CIO- Institutional Dennison T. Veru Appears on CNBC's “Closing Bell", "Why Investors Should Go for Growth, Not Safety"
Posted in Media Appearances
View Palisade Capital's Chief Investment Officer - Institutional Dennison T. Veru's appearance on the Liz Claman’s show, "Countdown to the Closing Bell", “Why Investors Should Go for Growth, Not Safety.”
Thursday, November 08, 2012
Jim Marrone joins Palisade Capital as Managing Director, Institutional Sales and Client Service
Posted in Announcements
Jim Marrone joined Palisade Capital Management in November 2012, as Managing Director, Institutional Sales and Client Service. In this role, Jim will lead Palisade’s institutional sales, marketing, and client service departments.
Read More
‹ First  < 27 28 29 30 31 >  Last ›
Latest Research and White Papers
Wednesday, May 04, 2022
The Case for SMID Cap - An Asset Class for the New Business Cycle
The lockdowns and flash recession which followed the beginning of the COVID-19 pandemic precipitated a reset of the global economy and initiated a new business cycle. Recent stock market weakness, however, is a cyclical correction in a secular bull market, and we believe the U.S. remains early in the recovery phase of this new cycle.
Find Out More and Request This White Paper

See all Research and White Papers



Select A Category

Connect with Us

One Bridge Plaza, Suite 1095, Fort Lee, New Jersey 07024 | (201) 585-7733 | Get Directions | Contact Us

Stay Informed

Sign up for our mailing list and stay up to date on the latest information and news from Palisade Capital Management.